Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?

BACKGROUND: Cyclophosphamide plus thalidomide as induction for multiple myeloma patients eligible for autologous stem cell transplantation may be a limiting factor for cell mobilization. The minimum acceptable mobilized peripheral blood stem cell count to prevent deleterious effects during transplan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Rev Bras Hematol Hemoter
Autores principales: Crusoe, Edvan de Queiroz, Higashi, Fabiana, Martinez, Gracia Aparecida, Barros, José Carlos, Bellesso, Marcelo, Rossato, Marina, Marret, Ana Cinira F., Chiattone, Carlos Sérgio, Hungria, Vania Tietsch de Moraes
Formato: Artigo
Lenguaje:Inglês
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2016
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5119677/
https://ncbi.nlm.nih.gov/pubmed/27863757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bjhh.2016.06.004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares